Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations and Comprehensive Loss

v3.21.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Revenues:    
Total revenues $ 10,000,000
Expenses:    
Research and development 30,139,000 48,566,000
General and administrative 23,779,000 20,705,000
Depreciation and amortization 4,586,000 7,819,000
Licensed technology impairment charge 32,916,000
Total expenses 91,420,000 77,090,000
Loss from operations (81,420,000) (77,090,000)
Interest and miscellaneous income 1,301,000 1,208,000
Interest and other expense (4,115,000) (400,000)
Net loss $ (84,234,000) $ (76,282,000)
Basic and diluted loss per common share $ (0.91) $ (1.51)
Weighted average number of common shares outstanding – basic and diluted 92,663,574 50,354,596
Other comprehensive loss:    
Change in unrealized losses related to  available-for-sale debt securities $ (10,000)
Comprehensive loss (84,244,000) (76,282,000)
License and Other Revenues [Member]    
Revenues:    
Total revenues $ 10,000,000